Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chemische Fabrik Kreussler
Chemische Fabrik Kreussler
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Asclera
Polidocanol
2010-03-30
2024-2032
Varicose veins
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Etrolizumab
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
Cycloplegics
dementia
,
cognitive dysfunction
,
allergic rhinitis
,
rhinitis
,
general anesthesia
,
neoplasms
,
male genital neoplasms
,
allergic rhinitis seasonal
,
allergic rhinitis perennial
,
replacement arthroplasty knee
,
replacement arthroplasty hip
,
hip fractures
,
blood coagulation
,
neuromuscular blockade
,
delayed emergence from anesthesia
,
postoperative nausea and vomiting
,
vomiting
,
nausea
Mydriatics
dementia
,
cognitive dysfunction
,
allergic rhinitis
,
rhinitis
,
general anesthesia
,
neoplasms
,
male genital neoplasms
,
allergic rhinitis seasonal
,
allergic rhinitis perennial
,
replacement arthroplasty knee
,
replacement arthroplasty hip
,
hip fractures
,
blood coagulation
,
neuromuscular blockade
,
delayed emergence from anesthesia
,
postoperative nausea and vomiting
,
vomiting
,
nausea
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use